GSK Alli Strategy Relies Even More On Users Spreading The Word
This article was originally published in The Tan Sheet
Executive Summary
Heading into its second year selling weight-loss drug alli over the counter, GlaxoSmithKline wants users to do the talking
You may also be interested in...
Sanofi Needs Switch Skills To Span Gap Between Rx And OTC Divisions
Sanofi-Aventis will need to build an infrastructure geared to Rx-to-OTC switch in order to make a successful U.S. consumer business out of its planned acquisition of Chattem and become established as a switch player
Sanofi Needs Switch Skills To Span Gap Between Rx And OTC Divisions
Sanofi-Aventis will need to build an infrastructure geared to Rx-to-OTC switch in order to make a successful U.S. consumer business out of its planned acquisition of Chattem and become established as a switch player
Sanofi Needs Switch Skills To Span Gap Between Rx And OTC Divisions
Sanofi-Aventis will need to build an infrastructure geared to Rx-to-OTC switch in order to make a successful U.S. consumer business out of its planned acquisition of Chattem and become established as a switch player